Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 19, 2022

SELL
$131.98 - $163.75 $12.5 Million - $15.6 Million
-95,000 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $10.2 Million - $12.9 Million
95,000 New
95,000 $12.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $353B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track California First Leasing Corp Portfolio

Follow California First Leasing Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California First Leasing Corp, based on Form 13F filings with the SEC.

News

Stay updated on California First Leasing Corp with notifications on news.